688351 微电生理
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.0040.3390.271-2.0501.388
总资产报酬率 ROA (%)0.9260.3150.250-1.8451.237
投入资产回报率 ROIC (%)0.9820.3310.264-2.0111.378

边际利润分析
销售毛利率 (%)59.09963.51269.10672.42972.607
营业利润率 (%)9.7152.3231.162-6.2764.083
息税前利润/营业总收入 (%)7.608-0.108-2.564-9.9002.809
净利润/营业总收入 (%)8.5761.7281.180-6.3014.064

收益指标分析
经营活动净收益/利润总额(%)23.480-510.112-196.339201.431-115.967
价值变动净收益/利润总额(%)63.061397.91536.30624.07715.061
营业外收支净额/利润总额(%)-13.136-36.285-1.8050.406-0.460

偿债能力分析
流动比率 (X)14.20815.75424.11710.88615.881
速动比率 (X)13.06014.48522.8039.92214.802
资产负债率 (%)7.9177.5806.51911.8438.049
带息债务/全部投入资本 (%)-0.071-0.094-0.657-2.299-2.500
股东权益/带息债务 (%)-137,504.832-103,502.962-14,867.720-4,216.963-3,972.376
股东权益/负债合计 (%)1,163.1071,219.1981,433.986744.3701,142.446
利息保障倍数 (X)-7.7780.0600.6922.751-2.238

营运能力分析
应收账款周转天数 (天)52.20049.70243.08248.64759.174
存货周转天数 (天)274.898313.741295.355273.540301.041